F
$ Value
$6K
Shares
9,360
Price
$1
Filed
Jul 31
Insider
Name
Doyle John Brendan
Title
Chief Financial Officer
CIK
0001840738
Roles
Officer
Transaction Details
Transaction Date
2025-07-29
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
425,350
Footnotes
Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025. | Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.
Filing Info
Doyle John Brendan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-16 | CGTX | ▲ | $11K ★ |
| 2025-07-29 | CGTX | A | $0 |
| 2025-07-29 | CGTX | F | $6K |
| 2025-05-01 | CGTX | F | $4K |
Other Insiders at CGTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Doyle John Brendan
Chief Financial Officer
|
$11K | — | 2026-04-16 |
|
Caggiano Anthony
Chief Medical Officer
|
$11K | — | 2026-04-16 |
|
Ricciardi Lisa
CEO & President
|
$10K | — | 2026-04-16 |